Literature DB >> 25529199

Dynamics and modulation of metabotropic glutamate receptors.

Philippe Rondard1, Jean-Philippe Pin2.   

Abstract

The metabotropic glutamate receptors (mGluRs) are glutamate-activated G protein-coupled receptors widely expressed in the central nervous system. The eight mGluRs subtypes modulate transmission at many synapses, and are interesting therapeutic targets for the treatment of many neurological and psychiatric diseases. In particular, their organization in multiple domains and subunits offers various possibilities for the development of drugs that modulate mGluRs activity with different efficacies. Recent structural, biophysical and functional analyses have provided new insights into the mechanism of mGluR activation and dynamics. They also revealed the structural bases of ligand efficacy then providing possible mechanism of action of partial agonists and allosteric modulators. These new findings are of great interest for the development of novel mGluR subtype-selective compounds.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25529199     DOI: 10.1016/j.coph.2014.12.001

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  20 in total

1.  Conserved Residues Control the T1R3-Specific Allosteric Signaling Pathway of the Mammalian Sweet-Taste Receptor.

Authors:  Jean-Baptiste Chéron; Amanda Soohoo; Yi Wang; Jérôme Golebiowski; Serge Antonczak; Peihua Jiang; Sébastien Fiorucci
Journal:  Chem Senses       Date:  2019-05-29       Impact factor: 3.160

2.  Illuminating the allosteric modulation of the calcium-sensing receptor.

Authors:  Hongkang Liu; Ping Yi; Wenjing Zhao; Yuling Wu; Francine Acher; Jean-Philippe Pin; Jianfeng Liu; Philippe Rondard
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-19       Impact factor: 11.205

3.  Antibodies targeting G protein-coupled receptors: Recent advances and therapeutic challenges.

Authors:  Mohammed Akli Ayoub; Pascale Crépieux; Markus Koglin; Marc Parmentier; Jean-Philippe Pin; Anne Poupon; Eric Reiter; Martine Smit; Jan Steyaert; Hervé Watier; Trevor Wilkinson
Journal:  MAbs       Date:  2017-05-05       Impact factor: 5.857

Review 4.  Control of neuronal excitability by Group I metabotropic glutamate receptors.

Authors:  Ana Maria Bernal Correa; Jennifer Diniz Soares Guimarães; Everton Dos Santos E Alhadas; Christopher Kushmerick
Journal:  Biophys Rev       Date:  2017-08-23

5.  Pituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.).

Authors:  Linghai Kong; Rebecca Albano; Aric Madayag; Nicholas Raddatz; John R Mantsch; SuJean Choi; Doug Lobner; David A Baker
Journal:  J Neurochem       Date:  2016-03-01       Impact factor: 5.372

6.  A Combination of Flow and Batch Mode Processes for the Efficient Preparation of mGlu2/3 Receptor Negative Allosteric Modulators (NAMs).

Authors:  Raveendra Panickar Dhanya; Ananda Herath; Douglas J Sheffler; Nicholas D P Cosford
Journal:  Tetrahedron       Date:  2018-03-30       Impact factor: 2.457

Review 7.  New paradigms in GPCR drug discovery.

Authors:  Kenneth A Jacobson
Journal:  Biochem Pharmacol       Date:  2015-08-08       Impact factor: 5.858

8.  Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity.

Authors:  Dai-Chi Liu; Joseph Seimetz; Kwan Young Lee; Auinash Kalsotra; Hee Jung Chung; Hua Lu; Nien-Pei Tsai
Journal:  Hum Mol Genet       Date:  2017-10-15       Impact factor: 6.150

9.  Novel Glutamatergic Treatments for Severe Mood Disorders.

Authors:  Minkyung Park; Mark J Niciu; Carlos A Zarate
Journal:  Curr Behav Neurosci Rep       Date:  2015-10-09

10.  Studies on lipase-catalyzed asymmetric synthesis of (S)-(hydroxymethyl)glutamic acid (HMG).

Authors:  Hiromasa Yoshioka; Masato Oikawa
Journal:  Springerplus       Date:  2015-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.